These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 9763355)
1. Hyperhomocysteinemia and atherothrombotic disease. de Jong SC; van den Berg M; Rauwerda JA; Stehouwer CD Semin Thromb Hemost; 1998; 24(4):381-5. PubMed ID: 9763355 [TBL] [Abstract][Full Text] [Related]
2. Pathogenesis of vascular disease in hyperhomocysteinaemia. Domagała TB; Undas A; Libura M; Szczeklik A J Cardiovasc Risk; 1998 Aug; 5(4):239-47. PubMed ID: 9919472 [TBL] [Abstract][Full Text] [Related]
3. Role of hyperhomocysteinemia in endothelial dysfunction and atherothrombotic disease. Austin RC; Lentz SR; Werstuck GH Cell Death Differ; 2004 Jul; 11 Suppl 1():S56-64. PubMed ID: 15243582 [TBL] [Abstract][Full Text] [Related]
4. Diabetes mellitus and hyperhomocysteinemia. van Guldener C; Stehouwer CD Semin Vasc Med; 2002 Feb; 2(1):87-95. PubMed ID: 16222599 [TBL] [Abstract][Full Text] [Related]
5. Homocysteine and risk for atherothrombotic events. Puddu P Cardiologia; 1999 Jul; 44(7):627-31. PubMed ID: 10476587 [TBL] [Abstract][Full Text] [Related]
6. [Homocysteine--a risk factor for atherosclerosis]. Debreceni L Orv Hetil; 2001 Jul; 142(27):1439-44. PubMed ID: 11481906 [TBL] [Abstract][Full Text] [Related]
7. Homocysteine and its role in the pathogenesis of atherosclerotic vascular disease. Sainani GS; Sainani R J Assoc Physicians India; 2002 May; 50 Suppl():16-23. PubMed ID: 12186151 [TBL] [Abstract][Full Text] [Related]
8. Abnormalities of vascular function in hyperhomocysteinaemia: relationship to atherothrombotic disease. Stehouwer CD; Jakobs C Eur J Pediatr; 1998 Apr; 157 Suppl 2():S107-11. PubMed ID: 9587036 [TBL] [Abstract][Full Text] [Related]
9. Endothelium-derived hyperpolarizing factor-mediated renal vasodilatory response is impaired during acute and chronic hyperhomocysteinemia. De Vriese AS; Blom HJ; Heil SG; Mortier S; Kluijtmans LA; Van de Voorde J; Lameire NH Circulation; 2004 May; 109(19):2331-6. PubMed ID: 15117854 [TBL] [Abstract][Full Text] [Related]
10. Homocysteine, coagulation, platelet function, and thrombosis. Coppola A; Davi G; De Stefano V; Mancini FP; Cerbone AM; Di Minno G Semin Thromb Hemost; 2000; 26(3):243-54. PubMed ID: 11011842 [TBL] [Abstract][Full Text] [Related]
11. Hyperhomocysteinemia, atherosclerosis and thrombosis. Cattaneo M Thromb Haemost; 1999 Feb; 81(2):165-76. PubMed ID: 10063987 [TBL] [Abstract][Full Text] [Related]
13. Folic acid reduces adhesion molecules VCAM-1 expession in aortic of rats with hyperhomocysteinemia. Li M; Chen J; Li YS; Feng YB; Gu X; Shi CZ Int J Cardiol; 2006 Jan; 106(2):285-8. PubMed ID: 16183151 [TBL] [Abstract][Full Text] [Related]
14. Homocysteine, a new cardiovascular risk factor, is also a powerful uremic toxin. Perna AF; Castaldo P; Ingrosso D; De Santo NG J Nephrol; 1999; 12(4):230-40. PubMed ID: 10493566 [TBL] [Abstract][Full Text] [Related]
15. Homocysteine and endothelial function in human studies. Moat SJ; McDowell IF Semin Vasc Med; 2005 May; 5(2):172-82. PubMed ID: 16047269 [TBL] [Abstract][Full Text] [Related]
16. Endothelial marker proteins in hyperhomocysteinemia. de Jong SC; Stehouwer CD; van den Berg M; Vischer UM; Rauwerda JA; Emeis JJ Thromb Haemost; 1997 Nov; 78(5):1332-7. PubMed ID: 9408014 [TBL] [Abstract][Full Text] [Related]
17. Hyperhomocysteinemia and lower extremity wounds. Schwartzfarb EM; Romanelli P Int J Low Extrem Wounds; 2008 Sep; 7(3):126-36. PubMed ID: 18757388 [TBL] [Abstract][Full Text] [Related]
18. Mechanisms of the atherogenic effects of elevated homocysteine in experimental models. Wilson KM; Lentz SR Semin Vasc Med; 2005 May; 5(2):163-71. PubMed ID: 16047268 [TBL] [Abstract][Full Text] [Related]